Src controls castration recurrence of CWR22 prostate cancer xenografts

Recurrence of prostate cancer (CaP) after androgen-deprivation therapy continues to have the greatest impact on patient survival. Castration-recurrent (CR)-CaP is likely driven by the activation of androgen receptor (AR) through multiple mechanisms including induction of AR coregulators, AR mutants...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Bing, Gillard, Bryan, Gao, Lingqiu, Eng, Kevin H, Gelman, Irwin H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892383/
https://www.ncbi.nlm.nih.gov/pubmed/24403252
http://dx.doi.org/10.1002/cam4.144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892383/
https://www.ncbi.nlm.nih.gov/pubmed/24403252
http://dx.doi.org/10.1002/cam4.144

Ejemplares similares